NEW YORK, May 24, 2022 --- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of ...
New York, April 13, 2022/PRNewswire/-- Insilico Medicine(“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that the ...
March 29, 2022, New York --- Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced ...
New York, New York, March 24, 2022 -- Insilico Medicine ("Insilico"), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, ...
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of ...
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, January 20, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company ...
New York and Hong Kong, Nov. 30, 2021 (4:00PM EST New York, 1PM California) – Insilico Medicine, an end-to-end artificial ...
